NEW YORK (GenomeWeb News) — Becton Dickinson today said that fiscal fourth-quarter revenues rose 13 percent as R&D spending increased 22 percent and profit soared 44 percent.
Total receipts for the three months ended Sept. 30 increased to $1.65 billion from $1.46 billion year over year.
BD said revenues from its Diagnostics segment grew 16 percent to $497.9 million, while Biosciences revenue rose 14 percent to $284.9 million. Revenue from the Medical segment rose 11 percent to $868.3 million.
BD’s R&D spending for the quarter rose to $100.4 million from $82.4 million year over year.
The firm’s profits for the quarter increased to $251 million from $174 million in the year-ago period.
For full-year 2007, BD reported revenue of $6.4 billion, an 11 percent increase over revenue of $5.7 billion in fiscal 2006. The firm’s 2007 profit was $881.3 million, a 17.1 percent gain on last year’s net earnings of $752.3 million.